Bronchicum® C (Bronchicum® C)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceThyme ordinary herb extractThyme ordinary herb extract
Similar drugsTo uncover
  • Bronchicum® C
    syrup inwards 
    A. Nattermann and Sie. GmbH     Germany
  • Bronchicum® C
    lozenges inwards locally 
    A. Nattermann and Sie. GmbH     Germany
  • Bronhoplant®
    syrup inwards 
    EVALAR, CJSC     Russia
  • Pertussin
    syrup inwards 
    FITO-BOT, LLC     Russia
  • Tussamag
    syrup inwards 
    Teva Pharmaceutical Enterprises Co., Ltd.     Israel
  • Tussamag
    syrup inwards 
    ratiofarm GmbH     Germany
  • Tussamag
    drops inwards 
    ratiofarm GmbH     Germany
    • Dosage form: & nbsplozenges
    Composition:
    Active ingredient:
    extract of thyme herb liquid - 100,000 mg
    Auxiliary components: sucrose, povidone, levomentol, cineole, acacia gum, stearic acid, silicon dioxide colloid, magnesium stearate.
    Description of the active ingredient: thyme herb extract is liquid.
    (Thymus vulgaris L., family Lamiaceae).
    Ratio of herb thyme to extractant 1: 2-2,5.
    Extractor: 10% ammonia solution, glycerin 85%, ethyl alcohol 90% (v / v), water; in the ratio 1: 20: 70: 109.
    Description:
    Round, slightly biconvex pastilles cream color with small impregnations.
    Pharmacotherapeutic group:Expectorant of plant origin
    ATX: & nbsp

    R.05.C.A   Expectorants

    Pharmacodynamics:
    It has an expectorant and mucolytic effect.
    Indications:
    As a symptomatic agent in the treatment of inflammatory diseases of the upper respiratory tract, accompanied by a cough with hard-to-recover sputum.
    Contraindications:
    Increased individual sensitivity to the components of the drug, chronic heart failure (in the stage of decompensation), severe violations of the liver and kidneys, children's age (up to 6 years).
    Pregnancy and lactation:
    The drug is not recommended for use during pregnancy and breastfeeding.
    Dosing and Administration:
    The lozenges dissolve in the oral cavity.
    Adults and children over 12 years of age should dissolve in the oral cavity 1-2 lozenges several times (up to 3 times) per day. Children from 6 to 12 years - 1 lozenge 3 times a day. The duration of the drug is determined by the severity of the symptoms of the disease and its duration.
    Side effects:
    Allergic reactions are possible (skin rash, urticaria, angioedema, swelling of the face and mucous membrane of the mouth and pharynx (angioedema)). In this case, stop taking the medication and consult a doctor.
    Interaction:
    It is not recommended simultaneous reception with antitussive drugs, as well as with drugs,reducing sputum production, as this makes it difficult to cough up thinned phlegm.
    Special instructions:
    One lozenge corresponds to 0.07 XE (bread units), which must be taken into account by patients with diabetes mellitus, as well as persons on a hypocaloric diet.
    If there is no improvement in the course of 5 days, consult a physician.
    Form release / dosage:
    Pastilles.
    Packaging:
    For 10 lozenges in a blister of PVC / aluminum foil. Two blisters together with instructions for use are placed in a cardboard box.
    Storage conditions:
    Store below 25 ° C.
    Keep out of the reach of children.
    Shelf life:
    3 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-010619/08
    Date of registration:26.12.2008 / 15.01.2013
    Expiration Date:Unlimited
    The owner of the registration certificate:A. Nattermann and Sie. GmbHA. Nattermann and Sie. GmbH Germany
    Manufacturer: & nbsp
    Information update date: & nbsp06.03.2017
    Illustrated instructions
      Instructions
      Up